+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ophthalmic Devices Market by Product Function [Surgical Devices Ophthalmic Diagnostic Devices, and Vision Care Devices]: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • ID: 5134134
  • Report
  • November 2020
  • Region: Global
  • 205 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • Essilor International SA
  • HAAG-Streit Holding AG
  • Johnson & Johnson
  • Nidek Co Ltd
  • Novartis AG
The global ophthalmic devices market was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.


  • phthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. They cover a wide range of design types and applications such as contact lenses, glasses, intraocular lenses, implants, lasers, diagnostics, and surgical instruments. These devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.

The growth of the global ophthalmic devices market is majorly driven by rise In incidence of vision disorders, technological advancements in ophthalmic devices such as intraocular lenses (IOLs), and increase in focus on customer training & education for use of ophthalmic devices, which would help in building the staff skills. In addition, increase in R&D developments for novel devices development related to vision error and surge in awareness related to devices used in ophthalmology contribute toward the growth of the global market. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. On the contrary, emerging countries such as China and India possess high growth potential, owing to improvement in healthcare infrastructure in these countries, which is anticipated to offer remunerative opportunities for the expansion of the market during the forecast period.

Depending on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices.

The ophthalmic diagnostic devices segment is subsegmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer.

The vision care devices segment is bifurcated into contact lenses and spectacle lenses
On a regional level, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share; however, Asia-Pacific is anticipated to grow with the highest CAGR of 4.6% during the forecast period.

The global ophthalmology devices market is highly competitive in nature, as major players have focused on the development and launch of innovative products to garner maximum share in the competitive market. The key players operating in the market include Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, HOYA Corporation, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry include Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the global ophthalmic devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ophthalmic devices market growth.

KEY MARKET SEGMENTS

By Product Function
  • Ophthalmic Surgical Devices
  • Refractive Error Surgical Devices
  • Glaucoma Surgical Devices
  • Cataract Surgery Devices
  • Vitreoretinal Surgical Devices
  • Ophthalmic Diagnostic Devices
  • Refractors
  • Corneal Topography Systems
  • Retinal Ultrasound Systems
  • Fundus Camera
  • Ophthalmoscopes
  • Optical Coherence Tomography Systems
  • Perimeters
  • Slit Lamps
  • Tonometer’s
  • Ophthalmic Vision Care Devices
  • Contact Lenses
  • Spectacle Lenses

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

List of key players profiled in the report
  • Novartis AG
  • Carl Zeiss Meditec AG
  • Essilor International S.A.
  • HAAG-Streit Holding AG
  • Johnson & Johnson
  • Nidek Co., Ltd.
  • Topcon Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Ophthalmic Systems AG
  • Hoya Corporation

LIST OF OTHER PLAYERS in the value chain (profiles not included in the report):
  • Sonomed Escalon
  • Gulden Ophthalmics
  • FCI Ophthalmics
  • Glaukos Corporation
  • STAAR Surgical GE Healthcare
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • Essilor International SA
  • HAAG-Streit Holding AG
  • Johnson & Johnson
  • Nidek Co Ltd
  • Novartis AG

Chapter 1: Introduction
1.1. Report Description
1.1.1. Key Benefits for Stakeholders
1.1.2. Key Market Segments
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
1.2.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. CXO Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Winning Strategies
3.2.2. Top Player Positioning, 2019
3.2.3. Key Forces Shaping the Global Ophthalmic Devices Market
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rise in Prevalence of Eye-Related Diseases Worldwide
3.3.1.2. Rapid Technological Advancements in Ophthalmic
3.3.1.3. Increase in Focus on Customer Training and Education Along With Awareness
3.3.1.4. High Adoption of Digital Devices Worldwide
3.3.2. Restraints
3.3.2.1. Low Awareness About Eye-Related Diseases
3.3.2.2. Dearth of Skilled Professionals
3.3.3. Opportunities
3.3.3.1. Potential Growth Opportunities in Emerging Nations for Ophthalmic Devices Manufacturers
3.4. Government Regulations
3.4.1. Fda
3.4.2. Ce Mark
3.4.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (Mhlw)
3.5. Impact of Covid-19 on Ophthalmic Devices Market
Chapter 4: Opthalmic Devices Market, by Product Function
4.1. Overview
4.1.1. Market Size and Forecast, by Region
4.2. Surgical Devices
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Refractive Error Surgical Devices
4.2.3.1. Market Size and Forecast
4.2.3.2. Market Size and Forecast, by Type
4.2.3.3. Excimers and Femtosecond Lasers
4.2.3.4. Market Size and Forecast
4.2.3.5. Microkeratomes
4.2.3.6. Market Size and Forecast
4.2.4. Glaucoma Surgical Devices
4.2.4.1. Market Size and Forecast
4.2.4.2. Market Size and Forecast, by Type
4.2.4.3. Implants and Stents
4.2.4.4. Market Size and Forecast
4.2.4.5. Glaucoma Drainage Devices
4.2.4.6. Market Size and Forecast
4.2.4.7. Glaucoma Laser Devices
4.2.4.8. Market Size and Forecast
4.2.5. Cataract Surgical Devices
4.2.5.1. Market Size and Forecast
4.2.5.2. Market Size and Forecast, by Type
4.2.5.3. Intraocular Lenses
4.2.5.4. Market Size and Forecast
4.2.5.5. Viscoelastic
4.2.5.6. Market Size and Forecast
4.2.5.7. Phacoemulsification Systems
4.2.5.8. Market Size and Forecast
4.2.6. Vitreoretinal Surgical Devices
4.2.6.1. Market Size and Forecast
4.2.6.2. Market Size and Forecast, by Type
4.2.6.3. Vitrectomy Machines and Vitrectomy Packs
4.2.6.4. Market Size and Forecast
4.2.6.5. Photocoagulation Lasers
4.2.6.6. Market Size and Forecast
4.2.6.7. Illumination Devices
4.2.6.8. Market Size and Forecast
4.3. Diagnostic Devices
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Refractors
4.3.3.1. Market Size and Forecast
4.3.4. Corneal Topography Systems
4.3.4.1. Market Size and Forecast
4.3.5. Retinal Ultrasound Systems
4.3.5.1. Market Size and Forecast
4.3.6. Fundus Camera
4.3.6.1. Market Size and Forecast
4.3.7. Ophthalmoscopes
4.3.7.1. Market Size and Forecast
4.3.8. Optical Coherence Tomography Systems
4.3.8.1. Market Size and Forecast
4.3.9. Perimeters
4.3.9.1. Market Size and Forecast
4.3.10. Slit Lamps
4.3.10.1. Market Size and Forecast
4.3.11. Tonometer
4.3.11.1. Market Size and Forecast
4.4. Vision Care Devices
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Contact Lenses
4.4.3.1. Market Size and Forecast
4.4.4. Spectacle Lenses
4.4.4.1. Market Size and Forecast
Chapter 5: Ophthalmic Devices Market, by Region
5.1. Overview
5.1.1. Market Size and Forecast
5.2. North America
5.2.1. Key Market Trends, Growth Factors, and Opportunities
5.2.2. Market Size and Forecast, by Product Function
5.2.3. Market Size and Forecast, by Region
5.2.4. U.S.
5.2.4.1. Market Size and Forecast, by Product Function
5.2.5. Canada
5.2.5.1. Market Size and Forecast, by Product Function
5.2.6. Mexico
5.2.6.1. Market Size and Forecast, by Product Function
5.3. Europe
5.3.1. Key Market Trends, Growth Factors, and Opportunities
5.3.2. Market Size and Forecast, by Product Function
5.3.3. Market Size and Forecast, by Region
5.3.4. Germany
5.3.4.1. Market Size and Forecast, by Product Function
5.3.5. France
5.3.5.1. Market Size and Forecast, by Product Function
5.3.6. UK
5.3.6.1. Market Size and Forecast, by Product Function
5.3.7. Italy
5.3.7.1. Market Size and Forecast, by Product Function
5.3.8. Spain
5.3.8.1. Market Size and Forecast, by Product Function
5.3.9. Rest of the Europe
5.3.9.1. Market Size and Forecast, by Product Function
5.4. Asia-Pacific
5.4.1. Key Market Trends, Growth Factors, and Opportunities
5.4.2. Market Size and Forecast, by Product Function
5.4.3. Market Size and Forecast, by Region
5.4.4. Japan
5.4.4.1. Market Size and Forecast, by Product Function
5.4.5. China
5.4.5.1. Market Size and Forecast, by Product Function
5.4.6. Australia Market Size and Forecast
5.4.6.1. Market Size and Forecast, by Product Function
5.4.7. India
5.4.7.1. Market Size and Forecast, by Product Function
5.4.8. Rest of Asia-Pacific
5.4.8.1. Market Size and Forecast, by Product Function
5.5. LAMEA
5.5.1. Key Market Trends, Growth Factors, and Opportunities
5.5.2. Market Size and Forecast, by Product Function
5.5.3. Market Size and Forecast, by Region
5.5.4. Brazil
5.5.4.1. Market Size and Forecast, by Product Function
5.5.5. Saudi Arabia Market Size and Forecast
5.5.5.1. Market Size and Forecast, by Product Function
5.5.6. South Africa
5.5.6.1. Market Size and Forecast, by Product Function
5.5.7. Rest of LAMEA
5.5.7.1. Market Size and Forecast, by Product Function
Chapter 6: Company Profiles
6.1. Carl Zeiss Meditec AG
6.1.1. Company Overview
6.1.2. Company Snapshot
6.1.3. Operating Business Segments
6.1.4. Product Portfolio
6.1.5. Business Performance
6.2. Essilor International S. A.
6.2.1. Company Overview
6.2.2. Company Snapshot
6.2.3. Operating Business Segments
6.2.4. Product Portfolio
6.2.5. Business Performance
6.2.6. Key Strategic Moves and Developments
6.3. Haag-Streit Holding AG
6.3.1. Company Overview
6.3.2. Company Snapshot
6.3.3. Operating Business Segments
6.4. Hoya Corporation
6.4.1. Company Overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Business Performance
6.4.5. Key Strategic Moves and Developments
6.5. Johnson & Johnson
6.5.1. Company Overview
6.5.2. Company Snapshot
6.5.3. Operating Business Segments
6.5.4. Product Portfolio
6.5.5. Business Performance
6.5.6. Key Strategic Moves and Developments
6.6. Nidek Co. Ltd.
6.6.1. Company Overview
6.6.2. Company Snapshot
6.6.3. Operating Business Segments
6.6.4. Key Strategic Moves & Developments
6.7. Novartis AG (Alcon-A Division of Novartis)
6.7.1. Company Overview
6.7.2. Company Snapshot
6.7.3. Operating Business Segments
6.7.4. Product Portfolio
6.7.5. Business Performance
6.8. Topcon Corporation
6.8.1. Company Overview
6.8.2. Company Snapshot
6.8.3. Operating Business Segments
6.8.4. Product Portfolio
6.8.5. Business Performance
6.9. Bausch Health Companies Inc.
6.9.1. Company Overview
6.9.2. Company Snapshot
6.9.3. Operating Business Segments
6.9.4. Product Portfolio
6.9.5. Business Performance
6.10. Ziemer Ophthalmic Systems AG
6.10.1. Company Overview
6.10.2. Company Snapshot
6.10.3. Product Portfolio
6.11. List of Mergers and Acquisitions (M&A) Activities
Note: Product cover images may vary from those shown
  • Novartis AG
  • Carl Zeiss Meditec AG
  • Essilor International SA
  • HAAG-Streit Holding AG
  • Johnson & Johnson
  • Nidek Co Ltd
  • Topcon Corporation
  • Valeant Pharmaceuticals International Inc
  • Ziemer Ophthalmic Systems AG
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...